Monday, February 13, 2012
Ocular Surgery News
The U.S. Food and Drug Administration has granted final approval for the Mitosol platform product for use in glaucoma surgery, according to Mobius Therapeutics. The company will begin producing and marketing the system immediately, a press release said.